Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy

Gamma delta T cells (γδT) are potent mediators of antitumor cytotoxicity and have shown promising efficacy in early phase clinical trials. Most is known about the tumoricidal properties of cells bearing the Vδ2 T cell receptor chain, but recent studies have demonstrated that cells with the Vδ1 chain and those with neither Vδ1 nor Vδ2 chains have properties which may make them more attractive anticancer effectors in adoptive immunotherapy.

[1]  Nigel Klein,et al.  Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells , 2014, Clinical Cancer Research.

[2]  R. Bast,et al.  Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies , 2014, Clinical Cancer Research.

[3]  K. Gustafsson,et al.  γδ T cells for cancer immunotherapy , 2014, Oncoimmunology.

[4]  Antoni Ribas,et al.  Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. , 2013, The New England journal of medicine.

[5]  L. Hurton,et al.  Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  G. Laurent,et al.  What lessons can be learned from γδ T cell-based cancer immunotherapy trials? , 2012, Cellular and Molecular Immunology.

[7]  L. Saraiva,et al.  Human γδ T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells , 2012, The Journal of Immunology.

[8]  B. Moser,et al.  Professional Antigen-Presentation Function by Human γδ T Cells , 2005, Science.

[9]  A. Lim,et al.  High frequency of circulating γδ T cells with dominance of the Vδ1 subset in a healthy population , 2000 .

[10]  O. Janssen,et al.  Activation and Activation‐Driven Death of Human γδ T Cells , 1991, Immunological reviews.

[11]  B. Moser,et al.  Professional antigen-presentation function by human gammadelta T Cells. , 2005, Science.

[12]  A. Lim,et al.  High frequency of circulating gamma delta T cells with dominance of the v(delta)1 subset in a healthy population. , 2000, International immunology.